Viral suppression is one of the most important outcomes of effective HIV treatment. Using the World Health Organization country observations retained for 2025, 94 countries can be compared on the same reference year. Their reported shares of people receiving HIV treatment who have suppressed viral loads range from 68% to 98%. The median country observation is 93% and the unweighted mean is about 91.5%. Those summary statistics give every country one vote; they are not population-weighted estimates of the share of all people on HIV treatment worldwide.
The indicator is named Percentage of people living with HIV receiving treatment who have suppressed viral loads. In practical terms, it asks whether treatment is achieving its intended virological outcome among people receiving care. This is closely connected to the third “95” in the global 95-95-95 framework: after diagnosis and access to antiretroviral treatment, viral suppression is the treatment outcome the programme is trying to achieve. Country-level percentages are useful for comparing programme outcomes, but they should not be used to interpret an individual laboratory result or to make treatment decisions.
Table of Contents
Only 94 of the retained country observations are from 2025
The latest-observation table contains 123 country rows, but it is not a 123-country 2025 dataset. Ninety-four rows are dated 2025 and 29 use earlier reference years from 2017 through 2024. Mixing all 123 latest values into a single ranking would make an older observation look directly comparable with a 2025 observation. For that reason, the map, mean, median, threshold counts, and country tables in this article use the synchronized 2025 subset only.
| Reference year | Country observations |
|---|---|
| 2025 | 94 |
| 2024 | 9 |
| 2023 | 7 |
| 2022 | 3 |
| 2021 | 5 |
| 2019 | 2 |
| 2018 | 1 |
| 2017 | 2 |
The distinction materially changes the low end of the table. Pakistan has a retained value of 41%, but it is dated 2024, so it is not described as the lowest 2025 country. Australia has 98% for 2024, Germany 98% for 2021, and Canada 95% for 2022; those values are also left out of the same-year ranking. Gray areas on the map therefore mean “no retained 2025 observation for this comparison,” not zero viral suppression.
Thirty-nine countries are at or above the 95% WHO target
WHO’s global HIV strategy sets a 2025 goal in which 95% of people living with HIV who are receiving treatment achieve viral suppression. Among the 94 countries with a 2025 observation here, 39 are at or above 95%, equivalent to 41.5% of the country rows. Another 29 are between 90% and under 95%, 18 are between 80% and under 90%, and eight are below 80%. The country-row median of 93% sits below the target threshold.
| 2025 viral suppression band | Countries | Share of 94 |
|---|---|---|
| 95% or more | 39 | 41.5% |
| 90–<95% | 29 | 30.9% |
| 80–<90% | 18 | 19.1% |
| Under 80% | 8 | 8.5% |
The 41.5% figure is a count of countries, not a global patient-level outcome. A small country and a country with a very large population each count as one row in this calculation. WHO’s global HIV estimates use different aggregation methods and population denominators. The threshold distribution here is best read as a way to see how many reporting country observations fall into each performance band, not as a substitute for a global treatment-cascade estimate.
Fourteen countries share the maximum reported 2025 value of 98%
The highest 2025 value in this dataset is 98%, and it is shared by 14 countries rather than belonging to a single first-place country: Bahamas, Botswana, Ethiopia, Cambodia, Kuwait, Lesotho, Luxembourg, Namibia, Rwanda, Saudi Arabia, Serbia, Slovenia, Eswatini, Thailand. Eight more countries are at 97%, including Algeria, Lao People’s Democratic Republic, Morocco, Nepal, the Philippines, Tanzania, Uganda, and Zambia. Because many observations are tied at the top, forcing a detailed first-to-fourteenth ranking would add precision that the data do not contain. The more useful distinction is whether a country is above or below the 95% programme target.
The map also warns against treating broad regions as uniform. Several countries in sub-Saharan Africa are in the highest band: Botswana, Ethiopia, Lesotho, Namibia, Rwanda, and Eswatini are at 98%; Tanzania, Uganda, and Zambia are at 97%; South Africa and Kenya are at 95%. Yet Djibouti is at 73%, Niger 75%, Mauritius 76%, and Sao Tome and Principe 78%. The same region therefore contains both countries that meet the target and countries that remain well below it.
Eight countries are below 80% in the synchronized 2025 subset
| Country | 2025 viral suppression |
|---|---|
| Afghanistan | 68% |
| Comoros | 69% |
| Timor-Leste | 70% |
| Djibouti | 73% |
| Niger | 75% |
| Mauritius | 76% |
| Qatar | 76% |
| Sao Tome and Principe | 78% |
Afghanistan has the lowest 2025 value at 68%, followed by Comoros at 69%, Timor-Leste at 70%, Djibouti at 73%, and Niger at 75%. Mauritius and Qatar are both at 76%, while Sao Tome and Principe is at 78%. These percentages do not measure HIV prevalence, the rate of new infections, or the share of the entire population living with HIV. They specifically describe viral suppression among the treatment population covered by this indicator.
The table also does not explain why a country is below the target. Viral-load testing access, continuity of treatment, medicine supply, retention in care, and the completeness of programme reporting can all matter, but those explanatory variables are not contained in this one country-value series. The map identifies differences in reported outcomes; it does not establish a causal ranking of health systems or policies.
Selected countries show how narrow and wide gaps coexist around the target
| Country | 2025 viral suppression |
|---|---|
| Ethiopia | 98% |
| Rwanda | 98% |
| Thailand | 98% |
| Philippines | 97% |
| United Republic of Tanzania | 97% |
| Brazil | 96% |
| India | 96% |
| Indonesia | 95% |
| Mexico | 95% |
| South Africa | 95% |
| Nigeria | 94% |
| Ghana | 92% |
| Malaysia | 88% |
| Afghanistan | 68% |
Thailand, Ethiopia, and Rwanda are at 98%; Tanzania and the Philippines are at 97%; Brazil and India are at 96%. South Africa, Kenya, Indonesia, and Mexico sit exactly on the 95% target line. Nigeria is just below at 94%, Ghana is 92%, and Malaysia is 88%. A one-percentage-point difference between 94% and 95% is numerically small, but it crosses the formal target threshold, which is why the map gives the 95%+ group its own class.
Several large countries that readers may expect to see—such as the United States, China, Japan, and the Republic of Korea—do not have a retained observation for this indicator in the WHO GHO country extract used for this analysis. Their values are not filled from another source and are not treated as zero. Preserving missingness is preferable to combining different indicators or reporting systems simply to make a map look complete.
What “viral suppression” means in HIV monitoring
Antiretroviral therapy suppresses HIV replication and reduces the amount of virus in the blood. In WHO’s SMART HIV indicator guidance, the ART.3 programme indicator uses a routine viral-load result below 1,000 copies/mL as the operational threshold for virological suppression in its monitoring definition. Suppression is a critical clinical and public-health outcome because sustained effective treatment protects the health of the person receiving care and greatly reduces the risk of onward HIV transmission.
A national percentage should still be kept separate from individual medical interpretation. Country indicators summarize programme or surveillance data across many people and can be affected by the population included, testing availability, reporting practices, and the reference period. An individual viral-load result has to be interpreted with the person’s actual laboratory report and clinical context. The country comparison here is therefore an epidemiological and programme-monitoring view, not personal medical advice.
Why the 95% threshold matters—but does not tell the whole HIV story
The WHO 2022–2030 global health sector strategy uses the 95-95-95 treatment cascade. The first 95 concerns knowing HIV status, the second concerns receiving antiretroviral therapy after diagnosis, and the third concerns viral suppression among people on treatment. High performance on the third step is essential, but it cannot compensate for gaps in the first two steps. A country can have excellent viral suppression among people who are already in treatment while still facing problems with diagnosis, treatment access, late presentation, or loss to follow-up.
For the same reason, a value above 95% should not be interpreted as a complete score for a national HIV response. Viral suppression is one outcome within a larger continuum of prevention, testing, treatment, retention, and equity. HIV prevalence, new infections, treatment coverage, mortality, age and sex disparities, and outcomes among key populations answer different questions. This article deliberately stays within the scope supported by the viral-suppression indicator rather than attributing the observed country gaps to causes not contained in the data.
Data source and calculation method
The country values come from the WHO Global Health Observatory HIV_VIRALLOADSUPPRESSEDART series. The broader 95-95-95 context is described on the WHO UHC Communicable and NCDs Dashboard. The operational programme definition of viral suppression can be reviewed in the WHO SMART Guidelines HIV indicators, while the policy target is set out in the WHO Global health sector strategies 2022–2030.
All same-year statistics in this article use only the 94 observations dated 2025. Missing values are not converted to zero, and older latest observations are not backfilled into 2025. The mean of about 91.5% and median of 93% are unweighted summaries across country rows. The choropleth uses four bands—under 80%, 80–<90%, 90–<95%, and 95% or more—so that the WHO target is visible directly on the map.
Frequently Asked Questions
What does HIV viral suppression among people receiving treatment measure?
It measures the percentage of people receiving HIV treatment whose viral load is suppressed. It is a treatment-outcome indicator and is not the same as HIV prevalence or incidence.
What is the WHO viral suppression target?
The third 95 in the 95-95-95 framework calls for 95% of people receiving HIV treatment to achieve viral suppression.
How many countries in the 2025 data are at or above 95%?
Thirty-nine of the 94 countries with a 2025 observation are at or above 95%. That is 41.5% of country rows, not a population-weighted global patient percentage.
Do gray countries on the map have 0% viral suppression?
No. Gray means there is no retained 2025 observation in this same-year comparison. Missing or older values are not converted to zero.
Related Maps
Green Map creates custom-edited map images using open geographic data sources such as geoBoundaries, Natural Earth, OpenStreetMap, and government open data.
These maps are edited visual materials, not raw data files, and are provided for education, documents, presentations, and graphic reference.
